RxDoctor Payments Data

Jay Oaks, DO

Vascular Surgery · Oklahoma City, OKNPI 1790786085

Payments from drug & device makers

What this record shows

16 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 29.2% of the total. Reporting peaked in 2023 at $2,460 and has fallen 80.6% since, to $478 in 2025. That places this record below the midpoint for vascular surgery clinicians in OK, where the typical reported total is $6,612.

$4,814in general payments, 2019–2025

Across 64 payments — averaging $75.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$1K
  • Medtronic$1K
  • Camber Spine Technologies LLC$986
  • Silk Road Medical, Inc.$696
  • Shockwave Medical, Inc$297
  • Surmodics, Inc.$100
  • plus $274 from 10 others

What the payments were for

  • Travel & lodging$2,64555%
  • Food & beverage$2,16945%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,814 in reported general payments places this provider in the 35th percentile of 35 vascular surgery providers in Oklahoma.

See all vascular surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$143,423
Medicare patients
290
Services billed
850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$40,637
XareltoRivaroxaban21$13,876
BrilintaTicagrelor12$5,599
ClopidogrelClopidogrel Bisulfate177$1,244
Cilostazol36$601
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$403
Warfarin Sodium13$384
Atorvastatin Calcium40$210
Rosuvastatin Calcium31$179
Gabapentin13$130
Pantoprazole Sodium24$122

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →